| pubmed-article:15934109 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15934109 | lifeskim:mentions | umls-concept:C0003873 | lld:lifeskim |
| pubmed-article:15934109 | lifeskim:mentions | umls-concept:C0086583 | lld:lifeskim |
| pubmed-article:15934109 | lifeskim:mentions | umls-concept:C0450442 | lld:lifeskim |
| pubmed-article:15934109 | lifeskim:mentions | umls-concept:C1524063 | lld:lifeskim |
| pubmed-article:15934109 | lifeskim:mentions | umls-concept:C0205460 | lld:lifeskim |
| pubmed-article:15934109 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:15934109 | pubmed:dateCreated | 2005-7-28 | lld:pubmed |
| pubmed-article:15934109 | pubmed:abstractText | To compare the use of biologic agents among persons with rheumatoid arthritis (RA) in managed care and fee-for-service settings. | lld:pubmed |
| pubmed-article:15934109 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15934109 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15934109 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15934109 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15934109 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15934109 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:15934109 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15934109 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15934109 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15934109 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15934109 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15934109 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15934109 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:15934109 | pubmed:issn | 0004-3591 | lld:pubmed |
| pubmed-article:15934109 | pubmed:author | pubmed-author:KatzPatricia... | lld:pubmed |
| pubmed-article:15934109 | pubmed:author | pubmed-author:YelinEdward... | lld:pubmed |
| pubmed-article:15934109 | pubmed:author | pubmed-author:TrupinLaura... | lld:pubmed |
| pubmed-article:15934109 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15934109 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:15934109 | pubmed:volume | 53 | lld:pubmed |
| pubmed-article:15934109 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15934109 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15934109 | pubmed:pagination | 423-30 | lld:pubmed |
| pubmed-article:15934109 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:15934109 | pubmed:meshHeading | pubmed-meshheading:15934109... | lld:pubmed |
| pubmed-article:15934109 | pubmed:meshHeading | pubmed-meshheading:15934109... | lld:pubmed |
| pubmed-article:15934109 | pubmed:meshHeading | pubmed-meshheading:15934109... | lld:pubmed |
| pubmed-article:15934109 | pubmed:meshHeading | pubmed-meshheading:15934109... | lld:pubmed |
| pubmed-article:15934109 | pubmed:meshHeading | pubmed-meshheading:15934109... | lld:pubmed |
| pubmed-article:15934109 | pubmed:meshHeading | pubmed-meshheading:15934109... | lld:pubmed |
| pubmed-article:15934109 | pubmed:meshHeading | pubmed-meshheading:15934109... | lld:pubmed |
| pubmed-article:15934109 | pubmed:meshHeading | pubmed-meshheading:15934109... | lld:pubmed |
| pubmed-article:15934109 | pubmed:meshHeading | pubmed-meshheading:15934109... | lld:pubmed |
| pubmed-article:15934109 | pubmed:meshHeading | pubmed-meshheading:15934109... | lld:pubmed |
| pubmed-article:15934109 | pubmed:meshHeading | pubmed-meshheading:15934109... | lld:pubmed |
| pubmed-article:15934109 | pubmed:meshHeading | pubmed-meshheading:15934109... | lld:pubmed |
| pubmed-article:15934109 | pubmed:meshHeading | pubmed-meshheading:15934109... | lld:pubmed |
| pubmed-article:15934109 | pubmed:meshHeading | pubmed-meshheading:15934109... | lld:pubmed |
| pubmed-article:15934109 | pubmed:meshHeading | pubmed-meshheading:15934109... | lld:pubmed |
| pubmed-article:15934109 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:15934109 | pubmed:articleTitle | Impact of managed care on the use of biologic agents for rheumatoid arthritis. | lld:pubmed |
| pubmed-article:15934109 | pubmed:affiliation | Rosalind Russell Medical Research Center for Arthritis, University of California, San Francisco 94143-0920, USA. yelin2@itsa.ucsf.edu | lld:pubmed |
| pubmed-article:15934109 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15934109 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:15934109 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:15934109 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:15934109 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:15934109 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15934109 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15934109 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15934109 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15934109 | lld:pubmed |
